An Innovative, High-Throughput Method of SNP Haplotyping

Information

  • Research Project
  • 6641045
  • ApplicationId
    6641045
  • Core Project Number
    R44HG002247
  • Full Project Number
    2R44HG002247-02
  • Serial Number
    2247
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/2000 - 24 years ago
  • Project End Date
    4/30/2005 - 19 years ago
  • Program Officer Name
    SCHLOSS, JEFFERY
  • Budget Start Date
    5/1/2003 - 21 years ago
  • Budget End Date
    4/30/2004 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    2
  • Suffix
  • Award Notice Date
    -
Organizations

An Innovative, High-Throughput Method of SNP Haplotyping

[unreadable] DESCRIPTION (provided by applicant): Objectives are refining a novel, high-throughput method for haplotype analysis of single nucleotide polymorphisms (SNPs) and developing assays for specific haplotypes of significant scientific/clinical and commercial relevance. Presently, no simple, reliable, accurate methods exist for high-throughput SNP haplotyping. Applications are; 1) screening large numbers of samples for haplotypes associated with susceptibility to a particular disease; 2) diagnostic tests for haplotypes associated with disease susceptibility, pharmacogenetic and immunologic profiling; 3) saturation genotyping using haplotypes to narrow candidate genomic regions defined by linkage studies based on individual SNPs; and 4) linkage disequilibrium and association studies of genes located in candidate genomic regions or candidate genes identified by other methods. [unreadable] [unreadable] Phase I activities converted a plate-based 2-SNP haplotyping assay to a multi-SNP bead-based assay yielding dramatic throughput and reproducibility improvements while decreasing cost, labor and time, and demonstrated utility in haplotyping the E-selectin gene. [unreadable] [unreadable] Phase II aims are: [unreadable] 1) To reduce assay development effort and assay cost; [unreadable] 2) To develop rapid, easy kits for haplotyping several cytokines of functional and clinical significance, including both individual and multiplexed assays [unreadable] 3) To develop assays for haplotypes of potential clinical/scientific/commercial value, identified in the scientific literature and/or HAPMap database for genes presumed to have value. [unreadable] [unreadable]

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    R44
  • Administering IC
    HG
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    626725
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:626725\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    POLYGENYX, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    WORCESTER
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01604
  • Organization District
    UNITED STATES